We thank Molou Lamah and Amara Nana Camara for collaborating with WHO and for their strong contribution to public health in Lola, Guinea. Mamadou Kourouma, Mamadou Baldé, Patric Honomou, Nestor Kolie, Oularé Mamadi, Kaduono Tamba, Kalaya Lamah, Angelo Loua, and Thomas Mollet all contributed to data collection and the measles vaccination campaign. Patient Kighoma exchanged data on measles cases in Lola and made a strong contribution to measles case management in Lola by distributing Vitamin A supplements.
Takahashi S, Metcalf CJ, Ferrari MJ, Moss WJ, Truelove SA, Tatem AJ, Grenfell BT, Lessler J, 2015. Reduced vaccination and the risk of measles and other childhood infections post-Ebola. Science 347: 1240–1242.
Doumtsop JG, Malano ER, Diallo IT, Sirimah C, 2014. An evaluation of the 2012 measles mass vaccination campaign in Guinea. Pan Afr Med J 17: 4.
Wolfson LJ, Strebel PM, Gacic-Dobo M, Hoekstra EJ, McFarland JW, Hersh BS; Measles Initiative, 2007. Has the 2005 measles mortality reduction goal been achieved? A natural history modelling study. Lancet 369: 191–200.
Orenstein WA, Bernier RH, Dondero TJ, Hinman AR, Marks JS, Bart KJ, Sirotkin B, 1985. Field evaluation of vaccine efficacy. Bull World Health Organ 63: 1055–1068.
De Serres G, Boulianne N, Meyer F, Ward BJ, 1995. Measles vaccine efficacy during an outbreak in a highly vaccinated population: incremental increase in protection with age at vaccination up to 18 months. Epidemiol Infect 115: 315–323.
Marin M, Nguyen HQ, Langidrik JR, Edwards R, Briand K, Papania MJ, Seward JF, LeBaron CW, 2006. Measles transmission and vaccine effectiveness during a large outbreak on a densely populated island: implications for vaccination policy. Clin Infect Dis 42: 315–319.
Wesseh CS, Najjemba R, Edwards JK, Owiti P, Tweya H, Bhat P, 2017. Did the Ebola outbreak disrupt immunisation services? A case study from Liberia. Public Health Action 7: S82–S87.
Mossong J, Muller CP, 2000. Estimation of the basic reproduction number of measles during an outbreak in a partially vaccinated population. Epidemiol Infect 124: 273–278.
Stan Development Team, 2015. RStan: The R Interface to Stan, Version 2.8.0. Available at: https://cran.r-project.org/web/packages/rstan/vignettes/rstan.html. Accessed April 5, 2015.
Vink MA, Bootsma MCJ, Wallinga J, 2014. Serial intervals of respiratory infectious diseases: a systematic review and analysis. Am J Epidemiol 180: 865–875.
Diekmann O, Heesterbeek JAP, Metz JAJ, 1990. On the definition and the computation of the basic reproduction ratio R0 in models for infectious diseases in heterogeneous populations. J Math Biol 28: 365–382.
Reliefweb-OCHA, 2017. Guinea Measles 2017 Outbreak. Available at: http://reliefweb.int/report/guinea/guinea-measles-outbreak-continues-spread. Accessed on March 15, 2017.
WHO Ebola Response Team, 2014. Ebola virus disease in West Africa—the first 9 months of the epidemic and forward projections. N Engl J Med 371: 1481–1495.
Meltzer MI, Atkins CY, Santibanez S, Knust B, Petersen BW, Ervin ED, Nichol ST, Damon IK, Washington MLCenters for Disease Control and Prevention (CDC), 2014. Estimating the future number of cases in the Ebola epidemic—Liberia and Sierra Leone, 2014–2015. Morb Mortal Wkly Rep Suppl 63: 1–14.
Lewnard JA, Ndeffo Mbah ML, Alfaro-Murillo JA, Altice FL, Bawo L, Nyenswah TG, Galvani AP, 2014. Dynamics and control of Ebola virus transmission in Montserrado, Liberia: a mathematical modelling analysis. Lancet Infect Dis 14: 1189–1195.
Van Kerkhove MD, Ferguson NM, 2012. Epidemic and intervention modelling: a scientific rationale for policy decisions? Lessons from the 2009 influenza pandemic. Bull World Health Organ 90: 306–310.